Xylem (NYSE: XYL) reported Q4 EPS of $0.89, in-line with the analyst estimate of $0.89. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.38 billion.

GUIDANCE:

Xylem sees FY2020 EPS of $2.96-$3.16, versus the consensus of $3.02.

• Xylem forecasts full-year 2020 organic revenue in the range of $5.3 to $5.35 billion, up one to three percent.
• Full-year 2020 adjusted operating margin is expected to be in the range of 14.0 to 14.5 percent, resulting in adjusted earnings per share of $2.96 to $3.16. This represents an increase of one to eight percent from Xylem’s 2019 adjusted results, excluding the impact of foreign exchange translation and a reduction in non-cash pension income. The Company’s adjusted earnings outlook excludes projected restructuring and realignment costs in the range of $35 million to $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

For earnings history and earnings-related data on Xylem (XYL) click here.